Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Ahsan Y. Khan"'
Autor:
Ahsan Y Khan, Matthew Macaluso
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2009, Iss default, Pp 23-31 (2008)
Ahsan Y Khan, Matthew MacalusoDepartment of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USAAbstract: Approximately 16 million people in the United States suffer from anxiety disorders alone, while
Externí odkaz:
https://doaj.org/article/f63f5d7fc50b4c749c15dcfa5823076f
Publikováno v:
Current Geriatrics Reports. 4:290-300
Caring for patients with schizophrenia in later life is emerging as a major concern as well as a challenge for practicing psychiatrists. The clinical presentation and course of this disorder in older patients differ from that of younger patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bbeaa63a6a34da67cc22be5548332b0
https://doi.org/10.1007/s13670-015-0149-2
https://doi.org/10.1007/s13670-015-0149-2
Publikováno v:
Kansas Journal of Medicine. 7:39-45
Background. Comprehensive treatment planning for psychiatric illnesses should be based on a biopsychosocial model of treatment to address the acuity and chronicity of these disorders. To achieve this goal, knowledge about pharmacological, psychologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fc382aee405f2b240d927a172b44d6c
https://doi.org/10.17161/kjm.v7i2.11483
https://doi.org/10.17161/kjm.v7i2.11483
Autor:
T. Scott Stroup, Ahsan Y. Khan, R. M. Steinbook, Ira D. Glick, J. Steven Lamberti, Robert M. Hamer, Henry A. Nasrallah, Neepa Ray, Matthew J. Byerly, Joseph P. McEvoy
Publikováno v:
Schizophrenia Research. 146:190-195
This study examined the clinical significance of switching from olanzapine, quetiapine, or risperidone to aripiprazole by examining changes in predicted risk of cardiovascular disease (CVD) according to the Framingham Risk Score (FRS) and metabolic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d343e160702c24671b826387befa1107
https://doi.org/10.1016/j.schres.2013.01.013
https://doi.org/10.1016/j.schres.2013.01.013
Publikováno v:
Kansas Journal of Medicine. 6:11-20
Background. Resilience is considered as the capacity to overcome adversity. Identifying psychiatric patients with lower resilience scores may assist mental health or other healthcare professionals in tailoring treatment to patients’ needs. The orig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::454e5c08b227f3ca3be5c28a243e5df5
https://doi.org/10.17161/kjm.v6i1.11430
https://doi.org/10.17161/kjm.v6i1.11430
Autor:
Ahsan Y. Khan, Sheldon H. Preskorn
Publikováno v:
Journal of Psychiatric Practice. 19:54-61
The authors propose a definition for rational multiple medication use (MMU). They then discuss how levels of diagnostic sophistication, ranging from symptomatic to syndromic to pathophysiologic to pathoetiologic, affect the ability to use multiple me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fcc5429229846cc1fa235649867514
https://doi.org/10.1097/01.pra.0000426327.57020.61
https://doi.org/10.1097/01.pra.0000426327.57020.61
Publikováno v:
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. 28(4)
Nonadherence to medication is a major problem for patients with schizophrenia. To counter this problem, pharmaceutical companies began developing depot antipsychotics. Although there are currently 5 first-generation and 6 second-generation depot anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17ac75d681cdea56a91ad4f0bd7f3cdf
https://pubmed.ncbi.nlm.nih.gov/27901520
https://pubmed.ncbi.nlm.nih.gov/27901520
Publikováno v:
Psychiatric Annals. 40:605-610
CME Educational Objectives 1. Identify which benzodiazepines are FDA approved for specific anxiety disorders. 2. Describe common adverse effects and safety issues relative to benzodiazepines. 3. Describe the evidence supporting the off-label use of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62c65b55465d08c8c2ece7158104d47b
https://doi.org/10.3928/00485713-20101123-03
https://doi.org/10.3928/00485713-20101123-03
Autor:
Kathrine Girrens, Matthew Macaluso, Megan M Dahmen, Faryal Ali, Ahsan Y. Khan, Robert J McHale
Publikováno v:
Journal of Psychiatric Practice. 16:289-296
Patients with schizophrenia have a greater incidence of being overweight or obese compared with the general population. Such individuals are often treated with second-generation (atypical) antipsychotics (SGAs), which are associated with weight gain,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce38d3b5adcaf7020cd4a2d264f69e5d
https://doi.org/10.1097/01.pra.0000388624.91039.a3
https://doi.org/10.1097/01.pra.0000388624.91039.a3
Publikováno v:
Journal of Psychiatric Practice. 16:58-62
A case is presented of the occurrence of an episode of mania apparently induced by desvenlafaxine, in a patient with a history of major depressive disorder and no apparent history of previous mania or hypo-mania. To our knowledge, this is the first s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c197c93bba1b049fa61022b4d1ae5f7a
https://doi.org/10.1097/01.pra.0000367780.18883.d8
https://doi.org/10.1097/01.pra.0000367780.18883.d8